Singh AN et al. identified UBE2N as a contributor to cancer development by quantitative proteomic mass spectrometry profiling and gene enrichment analysis on the induced invasive phenotype of prostate cancer cells [24]. This evidence concerns the gene UBE2N and prostate carcinoma.